| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2527130 | Clinical Therapeutics | 2013 | 15 Pages |
Abstract
No clinically meaningful QTc interval prolongation was observed in these healthy subjects who received ipragliflozin doses up to 600 mg/d for 7 days. ClinicalTrials.gov identifier: NCT01232413.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Wenhui PhD, Ronald MD, PhD, Anura PhD, Albert MD, PhD, Walter MSc, PharmD, Takeshi MSc, James PhD,